There are now 95 peer-reviewed publications demonstrating the safety, effectiveness, biomechanical or economic benefits of iFuse Technology™ SANTA CLARA, Calif., July 07, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a...
Orthopedic and Spine Specialist Added to Camber’s Growing Team of Expert Sales Professionals KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Camber Spine, a leading innovator in spine and medical technologies, has named Greg Reiswig...
TheraCell has surpassed 200 Fiber Anchors implanted, providing surgeons a solution for improved screw fixation. LOS ANGELES,July 6, 2021 /PRNewswire/ -- TheraCell Inc., a leading allograft solution company, today announced that over 200 of...
ATLANTA, July 6, 2021 /PRNewswire/ -- MiRus™ announced today that Mark Faucett has joined the company's Leadership Team as Vice President of Business Development effective June 1, 2021. Mr. Faucett has most recently served as...
Accelus to Offer Procedure-Enabling Technology with the Goal of Making Minimally Invasive Surgery (MIS) the Standard of Care in Spine. PALM BEACH GARDENS, Fla., July 06, 2021 (GLOBE NEWSWIRE) -- Integrity Implants...
GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, celebrates that ten years ago, the company introduced the Equinoxe® shoulder system’s augmented reverse...
SANTA CLARA, Calif., July 02, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced...
REGULATED INFORMATION The EIB financing to be used for Bone Therapeutics’ allogeneic cell therapy platform ALLOB and potential commercialization of enhanced viscosupplement JTA-004 Gosselies, Belgium, 1 July 2021, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris:...
According to Facts and Factors market research report, the Global Medical Device Market size & share revenue is expected to grow from USD 471 Billion in 2020 to reach USD...
Arthrex to receive exclusive rights to distribute and commercialize Celularity’s placental-derived biomaterial products for orthopedics and sport medicine in the United States. FLORHAM PARK, N.J. and NAPLES, Fla., July 01, 2021...